Scarica l'app Stockscreener
16.49
1.17%
0.19
Dopo l'orario di chiusura:
16.00
-0.49
-2.97%
Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie
Early development of Olema and Aurigene’s OP-3136 for breast cancer - BioWorld News
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Short Interest Update - MarketBeat
Rate Cut: Is Olema Pharmaceuticals Inc forming bullish engulfing patterns2026 Setups & Stock Portfolio Risk Management - baoquankhu1.vn
Olema Pharmaceuticals (NASDAQ:OLMA) Raised to "Sell" at Wall Street Zen - MarketBeat
Olema Pharmaceuticals posts new leadership role to advance clinical study compliance - Traders Union
Aurigene Oncology and Olema Pharmaceuticals patent KAT6A degradation inducers - BioWorld News
Olema Pharmaceuticals (NASDAQ:OLMA) Trading 7.7% HigherHere's What Happened - MarketBeat
Sentiment Review: Is Olema Pharmaceuticals Inc stock trending bullish2026 Investor Takeaways & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Market Review: How does Olema Pharmaceuticals Inc perform in inflationary periods2026 Institutional Moves & Daily Growth Stock Tips - baoquankhu1.vn
SG Americas Securities LLC Purchases Shares of 69,382 Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Olema oncology reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
OLMA SEC FilingsOlema Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
OLMA Technical Analysis & Stock Price Forecast - Intellectia AI
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 8.4%Still a Buy? - MarketBeat
Targets Report: How does Olema Pharmaceuticals Inc perform in inflationary periodsMarket Sentiment Review & Technical Buy Zone Confirmation - baoquankhu1.vn
A Look At Olema Pharmaceuticals (OLMA) Valuation After Earnings And New Shelf Registration Filing - Sahm
Hennion & Walsh Asset Management Inc. Increases Position in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals Inc at Citi Oncology Leadership Summit (Virtual) Transcript - GuruFocus
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Wolfe Research initiates coverage of Olema Pharmaceuticals (OLMA) with peer perform recommendation - MSN
Wolfe Research Initiates Coverage on Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals seeks senior director to lead accounting operations and financial reporting - Traders Union
Buybacks Report: Will Olema Pharmaceuticals Inc outperform its industry peers2026 Key Highlights & Expert Approved Trade Ideas - baoquankhu1.vn
Aug PostEarnings: What are analysts price targets for Olema Pharmaceuticals IncWeekly Stock Report & Reliable Intraday Trade Alerts - baoquankhu1.vn
Oppenheimer maintains Olema Pharmaceuticals (OLMA) outperform recommendation - MSN
Jim Cramer on Olema Pharmaceuticals: "Too risky for me" - MSN
Jim Cramer on Olema Pharmaceuticals: “Too Risky for Me” - Insider Monkey
Olema Shelf Registration Raises Questions On Dilution And Funding Flexibility - Yahoo Finance
Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential? - AOL.com
Invus entities disclose 4.5% stake in Olema (OLMA) on Schedule 13G - Stock Titan
Jefferies Adjusts Price Target for Olema Pharmaceuticals (OLMA) - GuruFocus
Olema Pharmaceuticals (OLMA) loses 33.4% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Jefferies Adjusts Price Target for Olema Pharmaceuticals (OLMA) | OLMA Stock News - GuruFocus
Olema Pharmaceuticals (OLMA) Is Down 6.7% After Posting Wider Losses And Filing New Stock Shelf - simplywall.st
Jefferies Financial Group Begins Coverage on Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat
Jefferies initiates Olema Pharmaceuticals stock with buy rating By Investing.com - Investing.com Canada
LifeSci Capital reiterates a buy on Olema Pharmaceuticals (OLMA) - MSN
JP Morgan Raises Price Target for Olema Pharmaceuticals (OLMA) | - GuruFocus
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
Olema Pharmaceuticals (OLMA) Drops 33.4% Over Past Month, Reasons Suggest a Potential Turnaround Ahead - Bitget
Olema Pharmaceuticals (OLMA) Loses 33.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Olema Pharmaceuticals (OLMA) Receives Updated Price Target by Go - GuruFocus
The Goldman Sachs Group Issues Pessimistic Forecast for Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price - MarketBeat
HC Wainwright Issues Optimistic Outlook for OLMA Earnings - MarketBeat
OLMA: Guggenheim Lowers Price Target While Maintaining Buy Ratin - GuruFocus
Olema Pharmaceuticals (OLMA) Receives Increased Price Target fro - GuruFocus
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting - Bitget
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):